Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies

References

• Maurice DM. Kinetics of topical applied drugs. In: Saettone MS, Bucci P, Speiser P, eds. Ophthalmic drug delivery, biopharmaceutical, technological and clinical aspects. Vol. 11. Fidia Research Series. Padova: Liviana Press; 1987:19–26
   Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Cavalli R, Rosa GM, Chetoni P, et al. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002;238:241–5
   PubMed Web of Science ®Google Scholar
• Muller RH, Maaßen S, Weyhers H, et al. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 1996;138:85–94
   Web of Science ®Google Scholar
• Guo L, Zhang X, Zhang S. An experimental study of inhibition of tetrandrine on posterior capsular opacification in rabbits. Zhonghua Yan Ke Za Zhi 2002;38:235–8
   PubMedGoogle Scholar
• Huang P, Xu Y, Wei R, et al. Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension. J Glaucoma 2011;20:183–8
   PubMed Web of Science ®Google Scholar
• Liang XC, Hagino N, Guo SS, et al. Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes – in vitro study. Phytomedicine 2002;9:377–84
   PubMed Web of Science ®Google Scholar
• Liu JP, Zhu JB, Du ZY, Qin B. Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles. Drug Dev Ind Pharm 2005;31:551–6
   PubMed Web of Science ®Google Scholar
• Luo QH, Zhao JM, Zhang XR, Pan WS. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 2011;403:185–91
   PubMed Web of Science ®Google Scholar
• Jia LJ, Shen JY, Zhang DR, et al. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 2012;50:523–9
   PubMed Web of Science ®Google Scholar
• Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physio 1987;253:228–31
   PubMed Web of Science ®Google Scholar
• Duchêne D, Wouessidjewe D. Pharmaceutical and medical applications of cyclodextrins. In: Dumitriu S, ed. Polysaccharides in medical applications. New York: Marcel Dekker; 1996:575–602
   Google Scholar
• Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005;11:127–52
   PubMedGoogle Scholar
• Aksungur P, Demirbilke M, Denkbas EB, et al. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery; cellular toxicity, uptake, and kinetic studies. J Control Release 2011;151:286–94
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Liu ZD, Zhang XH, Wu HY, et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37:475–81
   PubMed Web of Science ®Google Scholar
• Yang SC, Zhu JB. Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Dev Ind Pharm 2002;28:265–74
   PubMed Web of Science ®Google Scholar
• Emara LH, Badr RM, Elbary AA. Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev Ind Pharm 2002;28:795–807
   PubMed Web of Science ®Google Scholar
• Samy AM, Marzouk MA, Ammar AA, Ahmed MK. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique. Drug Discov Ther 2010;4:77–84
   PubMedGoogle Scholar
• Gupta H, Aqil M, Khar RK, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 2010;6:324–33
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm 2013;39:508–19
   PubMed Web of Science ®Google Scholar
• Mühlen AZ, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149–55
   PubMed Web of Science ®Google Scholar
• Gibaldi M. Regulating angiogenesis: a new therapeuric strategy. J Clin Pharmacol 1998;38:898–903
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release 2010;145:182–95
   PubMed Web of Science ®Google Scholar
• Iversen TG, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nanotoday 2011;6:176–85
   Web of Science ®Google Scholar
• Harush-Frenkel O, Debotton N, Benita S, Altschuler Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 2007;353:26–32
   PubMed Web of Science ®Google Scholar
• Nie Y, Ji L, Ding H, et al. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics 2012;2:1092–103
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Billotey C, Roger J, et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003;24:1001–11
   PubMed Web of Science ®Google Scholar
• Mutsaers SE, Papadimitriou JM. Surface charge of macrophages and their interaction with charged particles. J Leukoc Biol 1988;44:17–26
   PubMed Web of Science ®Google Scholar